ENXTPA:ORPersonal Products
L'Oréal (ENXTPA:OR) Expands Longevity Research, Is It Still 8% Below Fair Value?
L'Oréal (ENXTPA:OR) has drawn investor attention after announcing a multi year research partnership with NUS Medicine in Singapore, focused on longevity science and a joint lab for skin, scalp and hair.
See our latest analysis for L'Oréal.
L'Oréal's recent longevity partnership comes as the stock shows steady but unspectacular momentum, with a 90 day share price return of 7.34% and a 1 year total shareholder return of 0.54%. This suggests that expectations are firming rather than surging.
If...